Page last updated: 2024-10-29

ketanserin and Hemorrhagic Shock

ketanserin has been researched along with Hemorrhagic Shock in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"In a rat model of volume-controlled hemorrhagic shock (mean arterial pressure = 20-24 mm Hg) causing the death of all saline-treated animals within 30 min, the i."1.29Serotonin is involved in the ACTH-induced reversal of hemorrhagic shock in anesthetized rats. ( Bazzani, C; Bertolini, A; Ferrante, F; Fiore, L; Guarini, S, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazzani, C1
Fiore, L1
Ferrante, F1
Bertolini, A1
Guarini, S1

Other Studies

1 other study available for ketanserin and Hemorrhagic Shock

ArticleYear
Serotonin is involved in the ACTH-induced reversal of hemorrhagic shock in anesthetized rats.
    Pharmacology, 1996, Volume: 52, Issue:4

    Topics: Animals; Cosyntropin; Female; Fenclonine; Ketanserin; Male; Methysergide; Rats; Serotonin Agents; Sh

1996